Biphasic cytotoxic mechanism of extracellular ATP on U-937 human histiocytic leukemia cells: involvement of adenosine generation  by Schneider, C et al.
Biphasic cytotoxic mechanism of extracellular ATP on U-937 human
histiocytic leukemia cells : involvement of adenosine generation
C. Schneider a;b;*, H. Wiendl a;c, A. Ogilvie a
a Department of Biochemistry, University of Erlangen-Nuremberg, Erlangen, Germany
b Institute for Clinical Immunology, Department of Internal Medicine III, University of Erlangen-Nuremberg, Krankenhausstrasse 12,
D-91054 Erlangen, Germany
c Department of Neurology, University of Tu«bingen, Tu«bingen, Germany
Received 23 June 2000; received in revised form 17 November 2000; accepted 8 January 2001
Abstract
Since extracellular ATP can exhibit cytotoxic activity in vivo and in vitro, its application has been proposed as an
alternative anticancer therapy. In this study we investigated the mechanisms of ATP-induced cytotoxicity in a human
leukemic cell line (U-937). ATP added as a single dose exceeding 50 WM was cytostatic or even cytotoxic for U-937 cells.
Interestingly, growth inhibition by ATP (50^3500 WM) showed a biphasic dose response. Up to 800 WM, ATP was cytotoxic
in a dose-dependent manner (EC50 90 WM). In a range between 800 and 2500 WM, cell count was markedly higher despite the
higher ATP concentrations. The cytotoxic effect of ATP could be antagonized by addition of uridine as a pyrimidine source
and, alternatively, by addition of the nucleoside transmembrane inhibitor dipyridamole. The apoptosis-inducing adenosine
A3 receptor was not involved in measurable quantities, since (1) adenosine did not lead to an elevation of intracellular
calcium levels, and (2) an unselective A1ÿ3 antagonist (ULS-II-80) could not abrogate the cytotoxic effect. Experiments
monitoring extracellular nucleotide metabolism confirmed the assumption that the long-term production and continuous
uptake of adenosine, which is extracellularly generated by degradation of ATP, led to an intracellular nucleotide imbalance
with pyrimidine starvation. The biphasic dose response to higher ATP concentrations could be explained by the rapid
degradation of lower ATP concentrations (300 WM) to adenosine by serum-derived enzymes, whereas higher concentrations
(900 WM) only produced small amounts of adenosine due to forward inhibition of AMP hydrolysis by prolonged high ADP
levels. FACS analysis revealed that at lower adenosine concentrations (300 WM) a reversible G1 phase arrest of the cell cycle
was induced, whereas higher concentrations (1000 WM) triggered apoptosis. Considering ATP as a potential cytostatic drug,
our data have important implications concerning metabolic interactions of administered nucleotides. ß 2001 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Extracellular adenine nucleotides are known to ex-
hibit several physiological e¡ects such as inhibition
of platelet aggregation, mast cell secretion, immuno-
modulation, cardiovascular e¡ects, neurotransmis-
sion and others (for reviews see [1^3]). In the past
years, high interest has focused on another physiolog-
ical albeit unusual e¡ect of extracellular nucleotides,
namely the cytotoxic capabilities on transformed and
non-transformed cell lines. ATP has been shown to
be growth inhibitory or even cytotoxic for several
mammalian cell lines such as transformed mouse ¢-
broblasts [4], lymphoma cells [5], leukemia cells [6],
as well as in human cell lines such as leukemia cells
[7], pancreatic carcinoma cells [8], breast cancer cells
[9] and skin carcinoma cells [10] (reviewed in [3]).
Especially since transformed cells seem to be much
more susceptible than their non-transformed coun-
terparts, treatment with ATP was discussed as an
alternative cytostatic principle which could ¢nd pos-
sible application also in therapy of human diseases.
Rapaport reviewed the possible utilization of ATP
in the therapy of malignant tumors and AIDS [11].
In 1998 a clinical phase II study with patients su¡er-
ing from advanced lung cancer (NSCLC) showed
anticachectic e¡ects in two thirds of the patients
and disease stability, although no complete or par-
tial remissions were observed [12]. However, the mo-
lecular mechanisms underlying the cytotoxic e¡ects
of extracellular ATP are not resolved. Several mech-
anisms have been described, suggesting that the
mode of ATP-mediated cell death strongly depends
upon the cell type used for the study. For example,
in human breast cancer, ATP induces apoptosis by
P2-purinoceptor activation, independently of the ap-
plied ATP concentration (‘all or none’ e¡ect) [9]. In
contrast, in J774 mouse macrophages the applica-
tion of ATP resulted in colloidoosmotic lysis [13]
with release of intracellular molecules, induced e.g.
by activation of the pore-forming P2X7 receptor
(formerly known as P2Z) resulting in necrosis. In-
deed, apoptotic as well as necrotic cell death pat-
terns have been observed after treatment with ATP
or adenosine in several other murine and human cell
lines [9,13^16]. In addition to those purine receptor-
mediated cytotoxic signals also metabolic e¡ects
after cellular uptake of the ATP degradation prod-
uct adenosine are possible triggers of cell growth
inhibition or cell death. In a given cell, these e¡ects
can occur separately or as combined e¡ects. More-
over, ATP can elicit di¡erent distinct e¡ects in one
cell line depending on the applied concentration.
For example, in U-937 human histiocytic leukemia
cells it has been demonstrated previously that ATP
at low micromolar concentrations induces P2-puri-
noceptor-mediated di¡erentiation to a more mature
phenotype, whereas higher concentrations were cy-
totoxic [17]. Given the background of a possible
clinical application of extracellular ATP as a cyto-
static drug, the aim of the present study was to
investigate the cellular and molecular mechanisms
underlying ATP-mediated cytotoxicity in U-937
cells. Therefore we studied the e¡ects of single doses
of ATP or its degradation product adenosine on cell
proliferation, cell metabolism and morphology at
concentrations which might possibly be achieved in
vivo by intravenous infusions of ATP in a clinical
setting.
2. Materials and methods
2.1. Materials
RPMI 1640 medium and fetal calf serum (FCS)
were obtained from Boehringer (Mannheim, Ger-
many). Adenosine, AMP, ADP, ATP, uridine, ad-
enosine deaminase (ADA), dipyridamole and propi-
dium iodide (PI) were purchased from Sigma
(Munich, Germany), 2-[4-[(2-carboxyethyl)phenyl]-
ethylamino]-5P-N-ethylcarboxamidoadenosine (CGS-
21680), N6-cyclopentyladenosine (CPA), 3,7-dimeth-
yl-1-propargylxanthine (DMPX), 8-cyclopentyl-1,3-
dipropylxanthine (DPCPX), erythro-9-(2-hydroxy-3-
nonyl)adenine (EHNA) and N6-(3-iodobenzyl)adeno-
sine-5P-N-methyluronamide (IB-MECA) from Bio-
trend (Cologne, Germany), [5P-,8-3H]ATP (46 Ci/
mmol) and [2-3H]ATP (19.3 Ci/mmol) from Amer-
sham International. The non-selective adenosine
A1=2ab=3 antagonist ULS-II-80 was a generous gift
from Prof. Christa Mu«ller (University of Wu«rzburg,
Germany). Tissue culture plastics were from Nunc
(Wiesbaden, Germany), thin layer plastic sheets
coated with PEI-cellulose from Merck (Darmstadt,
Germany).
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2.2. Cell culture, cell proliferation
U-937 cells (human monocyte-like histiocytic lym-
phoma) obtained from the American Type Culture
Center (Rockville, MD, USA) were grown in RPMI
1640 medium supplemented with 10% native FCS,
2 mM glutamine and antibiotics (100 U/ml penicillin
and 100 Wg/ml streptomycin) at 37‡C in humidi¢ed
air with 5% carbon dioxide. Cultures were seeded at
5U104 cells/ml and grown in 90 mm petri dishes.
For cell proliferation assays, cells were diluted to a
density of 5U104 cells/ml if not otherwise indicated
and grown in 24-well £at bottom plates containing
1^2 ml medium/FCS per well. At times indicated,
aliquots were taken, and cells were counted in a
Fuchs-Rosenthal chamber. To obtain necrotic cells,
U-937 cultures were incubated for 90 min at 59‡C
[18], centrifuged and resuspended in fresh medium.
For inhibition of serum-derived enzymes, RPMI
1640 with 10% FCS was heated for 1 h at 56‡C [4]
immediately before the experiments and then cooled
down to a temperature of 37‡C for cell culture. For
assessment of morphology after treatment with dif-
ferent agents, cells were photographed with a Leitz
Fig. 1. Growth inhibition and cytotoxicity of U-937 cells induced by single doses of ATP or ADO. (a) Proliferation kinetics of U-937
cell cultures treated with 300 WM or 1500 WM ATP. (b,c) Dose-response curves for ATP (b) and adenosine treatment (c). The dose-re-
sponse relationship was calculated as percentage of untreated control cultures on the third day after addition of a single dose of ATP
or ADO.
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camera mounted on a Leitz microscope Diavert
975800. All experiments were done at least threefold,
each performed in duplicate. Figures show data from
a representative experiment if not otherwise indi-
cated.
2.3. Analysis of DNA content by £ow cytometry
Cells were grown at a density of 1U105/ml. At
times indicated, 500 Wl aliquots were taken, washed
once in phosphate-bu¡ered saline (PBS) and resus-
pended in 150 Wl of sodium citrate solution (0.1%)
containing 10 mg/ml propidium iodide and 0.15%
Triton X-100, and incubated for at least 8 h at 4‡C
in the dark. After incubation, 1 ml PBS was added
and the suspended nuclei were analyzed in an EPICS
XL/XL-MCL £ow cytometer. For DNA £uorescence
histograms, the number of events taken for building
the histograms was referred to the sample with the
smallest amount of events, always exceeding 7000
overall events.
2.4. Assay of extracellular nucleotide metabolism
(thin layer technique)
In order to measure extracellular nucleotide con-
centration and metabolism, tritium-labeled nucleo-
tides were incubated in 96-well plates containing 100
Wl of medium with or without cells (105/ml). Thin
layer chromatography was performed by a procedure
as described elsewhere [10]. Brie£y, at times indi-
cated, 3 Wl of the cell suspension supernatants were
taken away and directly spotted onto a PEI-cellulose
thin layer sheet, thus stopping the enzymatic reac-
tions as previously shown [19]. Marker nucleotides
were spotted on each starting point, and the nucleo-
tides were separated with water and 0.75 M LiCl at
room temperature. After drying, the separated nucle-
otide spots were visualized under ultraviolet light and
cut out. Radioactivity was measured in a liquid scin-
tillation counter in a mixture consisting of toluene,
0.5% PPO (2,5-diphenyloxazole) and 0.03% dimeth-
yl-POPOP [1,4-bis(4-methyl-5-phenyloxazol-2-yl)]-
benzene.
2.5. Measurement of cytosolic free Ca2+ in intact cells
A sample containing 107 cells was centrifuged and
incubated in 1 ml of RPMI 1640 medium supple-
mented with 50 mM HEPES and 2.5 mM probenecid
(pH 7.4). Then, 4 Wl of a fura-2/AM solution (1.0019
mg/ml DMSO; Sigma) was added and incubated for
15 min at 37‡C in the dark. Cells were diluted 1/5
with medium supplemented as described above and
incubated for another 15 min. After one washing
step, cells were resuspended in 6 ml of assay medium
(140 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM
CaCl2, 20 mM HEPES, 1 mM NaH2PO4, and 5.5
mM glucose, pH 7.4).
For £uorescence measurement, 1 ml of cell suspen-
sion was diluted with 1 ml of assay medium, and the
£uorescence intensity was followed under permanent
stirring with a Kontron Analytical £uorimeter (SFM
25) equipped with a chart recorder. Excitation wave-
length was set at 340 nm and emission wavelength at
510 nm. All measurements were carried out at room
temperature. Maximum £uorescence was determined
by adding Triton X-100 at a ¢nal concentration (f.c.)
of 0.1%, minimum £uorescence by addition of Tris-
EGTA to a f.c. of 12 mM, pH 7.4. Intracellular Ca2
levels ([Ca2]i), were calculated using the formula
[Ca2]i = Kd (F3Fmin)/(Fmax3F), where F is £uores-
cence and Kd (225 nM) the dissociation constant for
fura-2/Ca2 interaction at 37‡C [20].
3. Results
3.1. Cytostatic and cytotoxic e¡ects of adenine
nucleotides
3.1.1. ATP induced a biphasic cytotoxic e¡ect
ATP was added as a single dose to exponentially
growing U-937 cell cultures (5U104 cells/ml). After
3 days, doses between 100 and 800 WM ATP resulted
in dose-dependent cell growth inhibition with an es-
timated EC50 of about 90 WM (Fig. 1b). Below 200
WM, proliferation rate was reduced but still exponen-
tial (data not shown). At concentrations exceeding
200 WM, an extensive decrease of cell count was ob-
served. Under the light microscope, besides living
cells, cell debris was observed indicating cell death.
At 300 WM, the cell count on day 3 after ATP ex-
posure was calculated as 10 þ 7% of the untreated
control culture (n = 4, Fig. 1a,b). At concentrations
exceeding 800 WM, cell proliferation curves showed
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reduced but exponential growth kinetics. Maximum
cell count was observed at 1500 WM ATP (69 þ 7% of
control; n = 4, Fig. 1a,b). Thus, the growth inhibitory
e¡ect of ATP on U-937 cells exhibited a biphasic
concentration-response curve, a higher concentration
of the drug resulted in a lower cytotoxicity. Beyond
3500 WM, the cell number was again markedly less
(Fig. 1b). At these ATP concentrations after 3 days
in culture, necrotic cell morphology was observed
microscopically (not shown). All experiments were
performed with two U-937 cell lines obtained from
di¡erent sources.
3.1.2. The inhibitory e¡ect of ATP on cell growth was
mediated by generation of extracellular
adenosine
Extracellular ATP is degraded by membrane-
bound ectoenzymes [21,22] and/or by serum-derived
enzymes [4,23,24]. Thus, the degradation products
ADP, AMP and adenosine (ADO) were tested for
their ability to inhibit cell proliferation. All the ex-
periments (if not otherwise indicated) were per-
formed in RPMI medium supplemented with 10%
of native, not heat-inactivated FCS (being referred
to as untreated medium) to allow extracellular nucle-
otide metabolism, as in vivo. All the adenine nucleo-
tides as well as ADO inhibited cell growth at a con-
centration of 300 WM. ATP, ADP and AMP,
respectively, showed a cytotoxic e¡ect (Table 1a),
whereas adenosine resulted in a reduced but still ex-
ponential proliferation rate (data not shown). At a
higher concentration of 1500 WM, ADO as well as
ADP and AMP showed a clear cytotoxic e¡ect (Ta-
ble 1a), whereas after ATP treatment the U-937 cells
grew exponentially again (Fig. 1b). In untreated me-
dium, ADO showed a cell growth inhibitory e¡ect on
U-937 cells in a dose-dependent manner (EC50 350
WM) with reduced exponential cell growth in concen-
trations below approx. 1000 WM (Fig. 1c), and cyto-
toxicity with a decline in cell number at concentra-
tions exceeding 1000 WM. Inhibition of serum-
derived enzymes in order to inhibit extracellular nu-
cleotide metabolism by heating the medium prior to
addition of cells and nucleotides abolished the toxic
e¡ect of all nucleotides, whereas adenosine toxicity
was augmented (Table 1a). Cell viability and cell
growth kinetics of the control culture were not sig-
ni¢cantly altered in heat-inactivated medium com-
pared with untreated medium. These data support
the hypothesis that the cytotoxic e¡ect of the nucleo-
tides ATP, ADP and AMP, respectively, was medi-
ated by generation of extracellular adenosine. To
further corroborate this hypothesis, we performed
experiments in£uencing extracellular ATP metabo-
lism. Addition of adenosine deaminase to untreated
medium (Table 1b) partially abolished ATP cytotox-
icity immediately destroying generated adenosine.
ATP itself is not a known substrate for ADA. Ad-
Table 1
(a) Cytotoxicity of adenine nucleotides or adenosine on U-937
cells, given as a single dose, in untreated or inactivated medium
Medium Treatment Cell number (% of control)
at nucleotide concentration
300 WM 1500 WM
Untreated control 100 100
(RPMI 10% FCS) ATP 3 80
ADP 2 4
AMP 2 0.3
ADO 60 7
Heat-inactivated control 100 100
(90 min, 59‡C) ATP 119 95
ADP 98 92
AMP 99 85
ADO 19 2
(b) In£uence of several agents on ATP- or ADO-induced cyto-
toxicity
Medium Treatment Cell number
(% of control)
Heat-inactivated ADO 900 WM 10
(90 min, 59‡C) +DPR 10 WM 80
Untreated ADO 300 WM 60
(RPMI 10% FCS) +EHNA 1 WM 7
ATP 300 WM 3
+ADA 7.65 mU/ml 81
+DPR 10 WM 76
Inosine 300 WM 87
EHNA 1 WM 98
DPR 10 WM 71
ADA 7.65 mU/ml 100
(a) Cytotoxicity of adenine nucleotides on U-937 cells in un-
treated medium (RPMI 1640 supplemented with 10% native
FCS) or inactivated medium (after heat inactivation of the me-
dium). Data from one representative experiment are shown as
percentage of control culture on day 3 after exposure to a sin-
gle dose of the nucleotides. (b) In£uence of several agents on
cytotoxicity of ATP or ADO.
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enosine deaminase itself did not in£uence cell growth
kinetics. ADA deaminates ADO to inosine. This
product, when given itself, was only slightly inhibi-
tory to cell growth in untreated medium (Table 1b).
On the contrary, inhibition of adenosine degradation
by the selective adenosine deaminase inhibitor
EHNA (f.c. 1 WM) strongly augmented ADO-in-
duced cell growth inhibition in untreated medium
(Table 1b). Taken together, these results indicate
that the inhibitory e¡ect of adenine nucleotides on
U-937 cell growth was mainly mediated by long-term
generation of extracellular adenosine.
3.1.3. Mechanisms of cell growth inhibition by
adenosine
Extracellular adenosine interacts with cells mainly
by two mechanisms: (1) cellular uptake by trans-
membrane transporter proteins, or (2) speci¢c acti-
vation of adenosine receptors, i.e. P1-purinoceptors.
To investigate the mechanism responsible for the
ADO-mediated cytotoxic e¡ect, we performed ex-
periments interacting with either of the two path-
ways.
3.1.3.1. Cellular uptake of adenosine and pyrimi-
dine starvation. Addition of dipyridamole (10 WM,
DPR), an inhibitor of the nucleoside transmembrane
carrier [25,26] prior to treatment with 900 WM ADO
strongly prevented cytotoxicity (Table 1b). This ex-
periment was performed in heat-inactivated medium
to slow down adenosine degradation. Dipyridamole
alone had a mild growth inhibitory e¡ect itself (Table
1b). Dipyridamole clearly antagonized the inhibitory
e¡ect also of ATP in untreated medium (Table 1b).
Thus, adenosine uptake into the cells seemed to be
essential for the growth inhibitory e¡ect of purine
nucleotides and ADO on U-937 cells. Adenosine cy-
totoxicity can be intracellularly mediated by nucleo-
tide imbalance and consequent pyrimidine starva-
tion, a mechanism which can be overcome by
adding extracellular uridine to the medium as a py-
rimidine source [4,27,28]. 10 WM of uridine given as a
single dose prior to addition of 300 WM ATP led to
a strong reduction of cell growth inhibition after
3 days. The cell count (U104/ml) after treatment
with ATP together with uridine was 46 þ 8 compared
to 16 þ 5 with ATP in absence of uridine. The cell
count of the untreated control culture was 62 þ 4.
3.1.3.2. The A3 adenosine receptor was not measur-
ably involved. Certain agonists speci¢c for the A3
adenosine receptor have been reported to induce ap-
optosis in U-937 [29] and HL-60 cells [29,30]. Thus,
in addition to cellular uptake, a secondary cause of
adenosine-mediated toxicity could be activation of
adenosine A3 receptors. Binding of the agonist to
the A3 receptor leads to activation of phospholipase
C and subsequent formation of inositol-1,4,5-tris-
phosphate (IP3) and diacylglycerol (DAG). Besides
other e¡ects, IP3 induces an increase of intracellular
free Ca2 concentration [30]. After loading U-937
cells with fura-2, application of the selective A3 ago-
nist IB-MECA (60 WM) led to a rapid increase of
intracellular free Ca2 of v[Ca2]i = 42 nM (Fig. 2a
and Table 2), followed by a persisting elevation
(v[Ca2]i = 36 nM, Fig. 2a). Application of adenosine
in concentrations of 100 WM (Fig. 2b) and 1000 WM
(Fig. 2c), respectively, could not evoke any rise of
intracellular Ca2. The rapid decrease of £uorescence
observed after application of 1000 WM ADO (Fig.
2c) could most likely be explained by a dilution ef-
Fig. 2. Response of intracellular free [Ca2]i measured by the
fura-2 method after application of single doses of (a) the A3 ag-
onist IB-MECA at 60 WM, (b) adenosine at 100 WM or (c) 1000
WM, and water (d). The [Ca2]i response of U-937 cells elicited
by IB-MECA was a rapid [Ca2]i increase immediately after ap-
plication, reaching a peak concentration after about 1 min, fol-
lowed by a permanently sustained [Ca2]i level. Application of
adenosine did not induce a measurable [Ca2]i response (b,c).
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fect, since addition of an equal volume of water in
the negative control yielded a similar decline of £uo-
rescence (Fig. 2d). Within 10 min, the £uorescence
returned back to the baseline. Thus, adenosine itself
was not able to elicit measurable intracellular calci-
um responses. To exclude the possibility that admin-
istration of adenosine led to an inhibition of A3 re-
ceptor activation by simultaneously binding to A1
and/or A2 receptors, we added speci¢c adenosine re-
ceptor antagonists (DPCPX for the A1 receptor and
DMPX for the A2 receptor [31]) at 50 WM to the cells
prior to application of the agonists. After 10 min of
incubation, the agonists, IB-MECA (60 WM) or ad-
enosine (100 WM), respectively, were added. After
administration of adenosine, again no rise of intra-
cellular calcium level was detectable. A1/A2 receptor
antagonist pretreatment slightly augmented the cal-
cium response after IB-MECA application (data not
shown). On the other hand, activation of both A1
and A2 receptors with speci¢c agonists, CPA (50
WM) for the A1 receptor and CGS-21680 (50 WM)
for the A2 receptor [30,32], did not suppress
Ca2 mobilization following addition of 60 WM IB-
MECA (Table 2). CPA and CGS-21680 application
itself led to a slight increase of intracellular free cal-
cium (data not shown).
To further test involvement of the A3 receptor in
adenosine-mediated cytotoxicity, we investigated the
in£uence of an unselective A1;2;3 antagonist, ULS-II-
80, in cell growth experiments. ULS-II-80 inhibits the
human A3 receptor with a Ki of 0.67 WM (C. Mu«ller,
personal correspondence; Ki of other receptors: Ki
(A1 rat) = 0.15 WM; Ki (A2a rat) = 0.24 WM; Ki (A2b
human) = 1.05 WM). Therefore, concentrations up to
50 WM were used in our experiment to ensure com-
plete blockage of all ADO receptor subtypes. Adeno-
sine was added to U-937 cells in untreated medium
to a f.c. of 100 WM together with the ADA inhibitor
EHNA (1 WM). ULS-II-80 in concentrations up to 50
WM did not in£uence cytotoxicity of adenosine given
Fig. 3. Cell growth inhibition of U-937 by adenosine (values
are represented as the percentage of control cell count after
4 days in culture), and the in£uence of the adenosine deaminase
inhibitor EHNA (1 WM), the unselective A1=2ab=3 receptor an-
tagonist ULS-II-80, and the nucleoside transmembrane carrier
inhibitor dipyridamole (DPR, 10 WM), respectively. Experiments
were performed in untreated RPMI medium (10% FCS).
Table 2
Mobilization of intracellular calcium ions by adenosine or the A3 agonist IB-MECA with or without pretreatment with several drugs
Agonist Agonist concentration/volume Pretreatment v[Ca2]max
ADO 100 WM none 0 (n = 2)
DMPX 50 WM+DPCPX 50 WM 38 (n = 1)
1000 WM none 346 þ 9 (n = 2)
IB-MECA 60 WM none 42 þ 7 (n = 4)
CPA 50 WM+CGS21680 50 WM 56 þ 4 (n = 2)
Water 200 Wl none 355 þ 8 (n = 2)
Mobilization of intracellular calcium ions by ADO or the selective A3 agonist IB-MECA as measured by the fura-2 method, with or
without pretreatments with A1;2 receptor antagonists (DMPX and DPCPX) or A1;2 receptor agonists.
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together with EHNA, whereas addition of dipyrida-
mole (10 WM) prior to adenosine/EHNA treatment in
a parallel sample could clearly prevent the cells from
the cytotoxic e¡ect of adenosine (Fig. 3).
Taken together, these results support the hypoth-
esis that adenosine triggered cytotoxicity in U-937
cells by intracellular uptake and disturbance of intra-
cellular nucleotide metabolism. Activation of the A3
receptor as was reported for speci¢c A3 agonists (IB-
MECA and Cl-IB-MECA [29,30]) seemed not to be
involved in adenosine-mediated cytotoxicity.
3.1.4. ATP showed a biphasic dose response due to its
metabolism
As shown in Fig. 1, extracellular ATP exhibited a
biphasic dose-response e¡ect on cell proliferation.
Concentrations below 800 WM were more growth
inhibitory for U-937 cells than concentrations ex-
ceeding 900 WM. To explain this e¡ect, extracellular
nucleotide metabolism was measured at di¡erent giv-
en concentrations of ATP. The degradation kinetics
of 300 WM ATP using untreated medium and 1U105
U-937 cells per ml are shown in Fig. 4a. Extracellular
ATP was degraded to its metabolites ADP and AMP
(half-life 7 h), leading to generation of extracellular
adenosine. After 24 h, the amount of extracellular
adenosine was 28% of the total extracellular nucleo-
tides in the supernatant (300 WM taken as 100%),
which could be calculated as 84 WM. After 48 h,
the amount of adenosine was 58% (approx. 174
WM). To assess the quantitative involvement of ecto-
nucleotidases in nucleotide metabolism, we per-
formed experiments in cell-free medium. ATP metab-
olism was slower (half-life 10 h), but the adenosine
concentration after 48 h was only slightly less (55%
of total, 165 WM). This suggests that adenine nucle-
otide metabolism was mainly catalyzed by serum-de-
rived enzymes with acceleration by membrane-bound
ectoenzymes when cells were present (Fig. 4b). Me-
tabolism of 900 WM extracellular ATP (Fig. 4c) pro-
duced markedly less extracellular adenosine, after 24
h 3% of total nucleotide content (approx. 27 WM)
and after 48 h 5% (45 WM). At the same time a
prolonged high ADP level with accumulation of
AMP was observed. High ADP levels are known to
inhibit 5P-nucleotidase, which catalyzes AMP de-
phosphorylation as the critical step of adenosine for-
mation [1,21,33]. Our data suggest that more rapid
Fig. 4. Kinetics of degradation of ATP in RPMI 1640 medium supplemented with 10% FCS. In samples containing U-937 cells (a,c),
cells were grown in 96-well plates at a density of 1U105 cells per ml. After seeding, ATP at di¡erent doses was added. (a) 300 WM
ATP in cell-containing medium, (b) 300 WM ATP in cell-free medium, (c) 900 WM ATP in cell-containing medium.
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degradation of lower ATP concentrations subse-
quently led to lower amounts of generated ADP.
Therefore 5P-nucleotidase was inhibited to a lesser
extent, adenosine was generated in concentrations
capable of leading to cell growth inhibition. At high-
er ATP concentrations, ADO formation was for-
ward-inhibited by increased concentrations of ADP.
In conclusion, at higher ATP concentrations cells
survived with exponential cell growth kinetics due
to lack of adenosine formation.
3.2. Induction of apoptosis in U-937 cells by adenosine
and ATP
As demonstrated above, ATP cytotoxicity was
mediated by adenosine generated in ATP metabo-
lism. To de¢ne the phenotype of cell death induced
by ADO, we observed morphological alterations mi-
croscopically and alterations in DNA content by
£ow cytometry.
3.2.1. Adenine nucleotides induced apoptotic
morphological changes of U-937 cells
Changes in cell morphology like cell shrinkage,
condensation of cytoplasm, loss of normal intercel-
lular contacts, budding of the cell surface and apo-
ptotic body formation are considered as hallmarks of
apoptosis [34]. Cytosine arabinoside (ARA-C, 100
WM), a known apoptosis-inducing antimetabolite
[35], was used as a positive control in our experi-
ments. Cell shrinkage and budding of the cell surface
(Fig. 5B) was observed 4 h after treating U-937 cell
Fig. 5. Morphology of U-937 in culture treated with various agents as assessed by phase-contrast microscopy (U250). After seeding
to a density of 5U104 per ml in 24-well plates, agents as listed below were added as a single dose and photographs were taken at the
indicated times. (A) Control U-937 cells, no treatment, 48 h in culture. (B) ARA-C-treated cells (100 WM) after 4 h (induction of apo-
ptosis), (C) ARA-C-treated cells (100 WM) after 12 h. (D) Hyperthermic treatment (59‡C, 90 min) after 24 h (necrosis), (E) ATP (300
WM) after 24 h, (F) ATP (300 WM), pretreated with adenosine deaminase (7.65 mU/ml), after 24 h, (G) ATP (300 WM), pretreated
with uridine (50 WM), after 24 h, (H) ATP (300 WM), pretreated with ULS-II-80 (50 WM), after 24 h, (I) ADO (1000 WM) after 24 h,
(K) ADO (1000 WM) after 48 h. Arrows indicate apoptotic morphology.
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cultures with a single dose of 100 WM cytosine ara-
binoside. A few hours later, apoptotic bodies oc-
curred (Fig. 5C). In contrast, morphology of primary
necrosis induced by heating U-937 cells for 90 min at
59‡C [18] led to darkened, small cells, which did not
bud or disintegrate over the observed time (72 h, Fig.
5D).
Treatment with 300 WM ATP led to morphological
changes after 24^27 h similar to those observed with
ARA-C treatment (Fig. 5E). As was expected from
the results of the cell growth inhibition experiments,
these morphological changes were almost totally
abolished when the cells were pretreated with uridine
(Fig. 5F) or adenosine deaminase (Fig. 5G) prior
to ATP application. Pretreatment with the unselec-
tive adenosine A1;2;3 receptor antagonist ULS-II-80
had no in£uence on the induction of apoptotic mor-
phology following ATP treatment (Fig. 5H). Similar
morphological alterations were also elicited by ad-
enosine at concentrations exceeding 1000 WM (Fig.
5I,K), but already before 24 h. Thus, ATP via its
metabolite ADO was capable of inducing morpho-
logical changes of U-937 cells accompanying apopto-
sis.
Fig. 6. Assessment of apoptosis by £ow cytometry of U-937 cells. DNA content was analyzed by permeabilization of the cells with
Triton X-100 and DNA staining with propidium iodide. PI £uorescence histograms of U-937 cells, treated with the agents indicated,
the corresponding FSC/SSC light scatter pro¢les, and the relative composition of cell cycle phases are shown. FACS analysis was per-
formed 24 h (left) and 48 h (right) after addition of the agents, respectively. Data from a representative experiment, which was re-
peated twice. The arrow indicates shift of FSC/SSC towards a higher FSC and a higher SSC during apoptosis.
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3.2.2. Adenosine led to a hypodiploid DNA content in
U-937 cells
For detection of apoptotic U-937 nuclei, cells were
permeabilized at distinct times and their DNA was
stained with propidium iodide. The DNA content
pro¢le of untreated U-937 cells after 24 h of cultiva-
tion showed 49% of cells with an unreplicated
amount of DNA (G1 phase of the cell cycle, Fig. 6,
left), 20% having twofold DNA content (G2 phase
and mitosis, G2/M phase) and 29% with intermediate
amount of DNA (S phase). Addition of ARA-C led
to changes in DNA content consistent with previous
reports for apoptosis [36,37]: after 24 h a broad hy-
podiploid DNA peak occurred (A0 region), while
virtually no G2/M or S phase nuclei were observed
(Fig. 6). The forward scatter (FSC) and side scatter
(SSC) light pro¢les showed a clear shift of the £uo-
rescence towards a higher side scatter and a higher
forward scatter (Fig. 6).
Twenty-four hours after application of 300 WM
adenosine, a marked reduction of both G2/M phase
(9% vs. 20%, control) and S phase nuclei (21% vs.
29%, control) was observed with an accumulation of
G1 phase nuclei (68% vs. 49% in the control culture,
see Fig. 6). At this point of time (24 h), the number
of nuclei showing a FSC/SSC pro¢le of apoptotic
cells was not measurably higher than in the control
cultures (Fig. 6). As mentioned above, our cell
growth experiments showed that 300 WM ADO
yielded a retarded but nevertheless exponential
growth kinetic. The mentioned ¢ndings of DNA con-
tent analysis by £ow cytometry revealed that this
phenomenon was due to a G1 arrest. This halt in
proliferation following adenosine application was re-
versible, since after 48 h the number of G1 phase
nuclei dropped to 43%, and S phase nuclei increased
to 35%, the number of G2/M phase nuclei to 18%.
Application of a higher concentration of adenosine
(1000 WM) yielded a broad G1 peak (56% of total
events vs. 49%, control), an increase in S phase nuclei
(38% vs. 29%) and a rapid decrease in nuclei repre-
senting G2/M (4% vs. 20%, Fig. 6) after 24 h. This
had to be interpreted as nuclei losing DNA due to
apoptosis, since the analysis of the FSC/SSC showed
nuclei clearly shifting towards the apoptotic region of
higher FSC and higher SSC (Fig. 6). At this time
point, the amount of nuclei in the hypodiploid region
of apoptotic nuclei was no higher than in the control
culture (both 2%, Fig. 6). After 48 h, a broad peak in
the hypodiploid A0 region appeared (Fig. 6) indicat-
ing apoptosis. Taken together, ADO at lower con-
centrations (300 WM) induced a reversible G1 cell
cycle arrest, whereas higher concentrations (1000
WM) led to apoptosis.
4. Discussion
The present study has been performed to investi-
gate the molecular mechanisms underlying ATP-
mediated cytotoxicity in the well-known human leu-
kemic cell line U-937. In these cells, certain ATP
e¡ects such as induction of di¡erentiation [17], actin
polymerization [38] and Ca2 release from intracel-
lular stores [39] were shown to be mainly driven by
speci¢c ATP receptors. Besides induction of di¡er-
entiation at low ATP concentrations, ‘considerable
necrosis’ of undi¡erentiated U-937 at higher ATP
concentrations (exceeding 50 WM ATP) has been de-
scribed, but the mechanisms underlying this cyto-
toxic e¡ect have not been studied in further detail
[17]. Here we describe that cell growth inhibition of
U-937 cells induced by extracellular ATP, ADP and
AMP, respectively, was mainly mediated by their
common metabolite adenosine. In heat-inactivated
medium, where a rapid degradation of ATP via
extracellular nucleotidases is slowed down, the cyto-
toxic ability of all nucleotides was completely abol-
ished. Moreover, the rapid catabolism of extracellu-
larly generated adenosine by adding ADA to the
culture supernatant, almost totally abolished ATP
cytotoxicity. The EC50 for adenosine (350 WM) was
higher than the EC50 for ATP (90 WM), and adeno-
sine at equimolar concentrations exhibited a lower
cytotoxicity than the other purine nucleotides due
to its own further metabolism to innocuous metabo-
lites. These results are consistent with previous ob-
servations, where cytotoxicity of exogenous cAMP
was compared to exogenous adenosine in human
lymphoblasts [23]. Adenosine produced by degrada-
tion of cAMP is less e⁄ciently deaminated by ADA
than a given adenosine bolus. It was therefore pro-
posed that cAMP leads to a prolonged elevated ad-
enosine level in the medium being more toxic to the
cells than the same adenosine amount given as a
single dose.
BBAMCR 14729 17-4-01
C. Schneider et al. / Biochimica et Biophysica Acta 1538 (2001) 190^205200
Since addition of dipyridamole as an inhibitor of
the nucleoside transmembrane carrier strongly pre-
vented cell growth retardation, uptake of adenosine
into the cells seemed to be essential for triggering cell
death. These ¢ndings are consistent with previous
studies in 3T6 transformed mouse ¢broblasts and
chick embryonic sympathetic neurons [4,40], where
this mechanism for adenosine-mediated cell death
has been described. Addition of uridine abolished
adenosine cytotoxicity in U-937 cells indicating that
the cells died by inhibition of pyrimidine biosynthesis
and consequent pyrimidine starvation. This mecha-
nism has been discussed to be responsible for the
lymphocyte death in patients with ADA de¢ciency
[41].
However, the mechanism of adenosine-mediated
cytotoxicity strongly depends on the cell type. For
example, in some cell types (e.g. in human and
mouse thymocytes) adenosine triggers apoptosis by
receptor activation [42,43]. On the other hand, in rat
chroma⁄n cells, apoptosis is induced by 2P-dAdo,
but not adenosine, and nucleoside transmembrane
carrier inhibitors or pyrimidine precursors have no
in£uence on this process [44]. Tanaka and colleagues
described the induction of apoptosis in HL-60 cells
by adenosine, which could not be prevented by any
of the known adenosine receptor antagonists at that
time [15]. When speci¢c agonists for the A3 adeno-
sine receptor were available [45], the induction of
apoptosis of HL-60 cells after application of selective
A3 agonists was published [30]. Since speci¢c A3 re-
ceptor agonists were not known at the time when
Tanaka and colleagues published their results, it
has been concluded that adenosine induces apoptosis
of HL-60 cells by binding to the A3 receptor. How-
ever, since Tanaka and colleagues observed an antag-
onism of adenosine cytotoxicity by dipyridamole, it
seems unlikely that only the direct A3-mediated cy-
totoxicity could account for this e¡ect. Another
study showed that selective A3 agonists were capable
to induce apoptosis via A3 receptor activation also in
U-937 cells [29]. In our study, (1) adenosine itself
could not elicit the typical intracellular Ca2 re-
sponses following A3 receptor activation and (2) cy-
totoxicity of adenosine could not be abolished by an
unselective adenosine receptor antagonist. Thus, ad-
enosine obviously exhibited cytotoxicity by intracel-
lular uptake leading to pyrimidine starvation rather
than acting via direct A3 receptor stimulation. How-
ever, our data do not exclude some involvement of
the A3 receptor in general. Therefore, in U-937 cells
at least two distinct modes of cytotoxic adenosine
action might exist. It remains to be determined to
which extent each of them contributes to cell death
observed after adenosine application.
Testing a broad range of ATP concentrations for
inhibition of cell growth and monitoring the extra-
cellular metabolism of nucleotide degradation, we
observed that forward inhibition of extracellular
AMP metabolism at higher ATP concentrations led
to a reduced generation of adenosine. This inhibition
most likely accounts for the observed biphasic dose-
response kinetic in U-937 with survival of more cells
at higher ATP concentrations. Extracellular degrada-
tion of 300 WM ATP produced a more than sixfold
higher adenosine amount than metabolism of 900
WM because of a prolonged high ADP concentration
in the extracellular medium leading to inhibition of
5P-nucleotidase. In YAC-1 cells, a reduced 51Cr re-
lease used as a marker for ATP-triggered lysis was
observed at rising ATP concentrations [14]. Since
supplementation of Ca2 could overcome this e¡ect,
the availability of extracellular Ca2 seemed to be a
limiting factor for the cytotoxic ATP e¡ect. In U-
937, where cytotoxicity of ATP is mediated by ad-
enosine generation and its intracellular uptake, sup-
plementation of the cell culture medium with Ca2
did not augment cytotoxicity at higher ATP concen-
trations, but vice versa abolished the cytotoxicity of
all the tested ATP concentrations most likely due to
chelation of ATP in the culture supernatant (C.
Schneider, unpublished results). Another explanation
for the observed biphasic dose response might be the
blockage of a nucleoside transmembrane carrier by
adenine at higher concentrations. This degradation
product of adenosine has been shown to block a
low a⁄nity subtype of the nucleoside transmembrane
carrier in smooth muscle [25]. At concentrations high
enough to inhibit the carrier of smooth muscle cells
(100 WM), adenine had no in£uence on adenosine
uptake and cytotoxicity of U-937 cells (C. Schneider,
unpublished results). A biphasic concentration re-
sponse for ATP-induced release of arachidonic acid
(AA) in cAMP-di¡erentiated HL-60 cells has been
previously described [46]. Lower ATP concentrations
(IC50 3.2 WM) stimulated AA release, higher concen-
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trations (IC50 90 WM) inhibited AA release. This phe-
nomenon has been explained by the existence of two
distinct purinergic receptors. ATP at low concentra-
tions only binds to a high a⁄nity purinoceptor me-
diating the stimulatory e¡ect, ATP at higher concen-
trations also binds to another receptor with low
a⁄nity mediating the inhibitory e¡ect. Ca2-mobiliz-
ing purinergic receptors have been described to be
expressed on U-937 cells [17]. Since our data demon-
strated adenosine and not ATP being responsible for
the observed cytotoxic e¡ect in this cell line, di¡er-
ential purinoceptor involvement can be ruled out as
an explanation for the biphasic cytotoxicity phenom-
enon. Another example for an ATP e¡ect with a
biphasic dose-response curve has been reported for
glucose production in hepatocytes [47]. Stimulation
of glucose production by ATP is mediated via a P2-
purinergic pathway, whereas ATP-derived adenosine,
which is taken up into the cells, inhibits this produc-
tion. Thus, ATP and adenosine act in an antipodic
manner. Such an explanation of the observed bipha-
sic cytotoxicity of ATP on U-937 cells can also be
ruled out, since, as mentioned above, adenosine itself
is the metabolite responsible for ATP toxicity, which
means that ATP and adenosine act synergistically
toxic on U-937 cells. This novel observation of a
biphasic dose response to cytotoxic ATP treatment
seems to be a highly cell-speci¢c phenomenon. So
far, to our knowledge, it has not been described in
any other cell line. Even closely related other human
leukemia cells, such as HL-60, exhibit a concentra-
tion-dependent cytotoxicity, where rising ATP con-
centrations correlate with higher rates of cell death
[48]. Interestingly, in HL-60 the mechanism for ATP-
induced cell death is the same as in U-937, namely
the generation of adenosine. We tested several other
cell lines for ATP-induced cytotoxicity (K-562, hu-
man chronic myelogenous leukemia; CCRF-CEM;
acute lymphoblastic leukemia cell line; A-431, hu-
man skin carcinoma; data not shown). As in HL-
60, in K-562 and A-431 ATP did not exhibit a bi-
phasic dose response. In contrast, in CCRF-CEM
cells again a biphasic dose response with a better
survival at higher ATP concentrations, similar to
U-937, was observed. The reason for this speci¢city
yet remains to be determined. One hypothesis would
be that those cells which are dose-dependently killed
are highly susceptible for the toxic e¡ects even of
small amounts of extracellular adenosine, whereas
cell lines showing biphasic dose responses are less
sensitive and survive. Our data so far cannot exclude
any contribution of uncleaved ATP to the cytotoxic
e¡ect on U-937. Since the role of the P2X7 puriner-
gic receptor in mediating cytotoxicity and apoptosis
is well established [49^51], we performed experiments
where U-937 cells were pretreated with oxidized ATP
as an irreversible P2X7 antagonist [52]. Unfortu-
nately, the cells did not tolerate the addition of oxi-
dized ATP (100 WM or 300 WM, respectively) such
that any succeeding experiments could not be per-
formed (data not shown). However, a strong argu-
ment against uncleaved ATP as the cytotoxic princi-
ple in U-937 cells is the ¢nding that in heat-
inactivated medium lacking nucleotide metabolizing
enzymes, ATP nearly completely lost its cytotoxic
e¡ect. Moreover, addition of adenosine deaminase
to ATP-treated U-937 cultures abolished cytotoxic-
ity. Hence, the role of the P2X7 receptor in the cy-
totoxicity of ATP to U-937 cells should in fact be of
subordinate importance.
To further characterize the adenosine-mediated
cell death in U-937, we analyzed cells by £ow cyto-
metry, which have been treated with single doses of
adenosine. At a moderate concentration of adenosine
(300 WM), which leads to reduced cell proliferation
rate with no apparent cell death, a marked increase
of cells in the G1 phase and a decrease of cells both
in S and G2/M phase was observable 24 h after ad-
enosine administration. This indicates that adenosine
uptake and subsequent nucleotide imbalance led to
an arrest in the G1 phase of the cell cycle. After
application of a higher concentration of adenosine
(1000 WM), which was cytotoxic in cell proliferation
experiments, nuclei with hypodiploid DNA content,
considered as a hallmark of apoptosis [36], occurred.
The morphology of adenosine-treated U-937 cells re-
sembled that obtained by treating the cells with the
apoptosis-inducing drug ARA-C. Taken together,
these results indicate that inhibition of cell prolifer-
ation by adenosine at lower concentrations was
mediated by cell cycle arrest, whereas higher concen-
trations of adenosine triggered apoptosis.
Considering usage of ATP as an antitumoral
agent, millimolar ATP concentrations could be
achieved in vivo by intravenous infusion of the
nucleotide. Such concentrations may be harmful to
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non-transformed cells while, at the same time, certain
tumor cells, e.g. leukemia cells, complying with U-
937 would escape cytotoxicity due to the described
biphasic e¡ect. Prolonged high ADP levels to inhibit
5P-nucleotidase might also be achieved in vivo, but
most probably only over a short period of time be-
cause of rapid further degradation. Adenosine gen-
erated in blood vessels is e¡ectively removed from
circulation by uptake into erythrocytes [24] and by
deamination by plasma enzymes [28], but it might be
conceivable that a solid tumor could be attacked by
su⁄cient amounts of toxic adenosine after systemic
application of ATP. The in vivo action of adenine
nucleotides and adenosine is a complex network,
strongly depending on the cell type investigated and
its receptor equipment. Our results prompt the no-
tion that the degradation to adenosine and its intra-
cellular uptake should be considered an important
mechanism for assumed ‘ATP e¡ects’.
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